Leveraging Registered Reports to increase transparency in trial publication – Open Pharma - Innovations in medical publishing

"Publication bias undermines the credibility of clinical trial reporting and negatively affects the reputation of pharma sponsors. Registered Reports (RR) is a peer review process designed to eradicate publication bias, enhance research publication quality and assist clinicians in appraising true drug efficacy and safety. In this article, we illustrate how RR could be harmonized with the US Food and Drug Administration (FDA) drug review process and leveraged to increase trust in pharma-funded research...."